Tevogen TVGN
NASDAQ TVGN
$6.53 -0.17 (-2.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Tevogen (TVGN) Convertible Debt (2023)

Updated

Tevogen (TVGN) posted Convertible Debt of $14.22 million for Q4 2023.

Analysis

Tevogen (TVGN) Convertible Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Tevogen 27.79 Mn 27.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 14.22 Mn
API Access

Tevogen Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=TVGN&period=max&api_key=YOUR_API_KEY